image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Fonix Mobile

November 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FNX
  • Price:
  • 206.5p
Final results from mobile payments business Fonix were in line with the upgrades that followed its pre-close update in July. Gross profit rose 14% to £15.1m and includes a £1.5m contribution from Rest of Europe / Ireland following recent expansion. UK gross profit only rose 2%, impacted by some customers suspending campaigns following the death of Queen Elizabeth in H1. Recent contract wins, such as the expanded ITV partnership, will see more robust growth. Investment in the platform’s peak load capacity, the launch of a subscription engine for charity customers in autumn and the development of broader payment options, enabling Fonix to seamlessly switch between phone-paid billing and traditional payment methods,  will also suppor ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author